Cory Sejo, MD

🚲🪴🫀
2nd year cardiology fellow at @UCCardsFellows | 2025 @CardioNerds fellow

[Sukriti Banthiya @sukritibanthiya]

1/ Advanced platelet therapy by Dr. @MarcBonaca at #HeartofCardiology

[Tyrese Haliburton @Hali]

Alex Pretti was murdered.

[Mark Belkin @MarkBelkinMD]

ICYMI! Read-up on the highlights from @ChiHForum #ChiHemos2025

Thank you to the @CardioNerds, @AHajduczok, & @JCardFail team for putting this together!

Save-the-Date for the 3rd Annual @ChiHForum: 11/6/2026!

@CocoSejo @RSteinbergMD @catweneboah
https://t.co/gFAaAUKoL2

[EHJCVI Editor-in-Chief @EHJCVIEiC]

#EHJCVI When should we use #EchoFirst in cardiovascular emergencies and critical care?
The new EACVI–ACVC consensus highlights its key role in cardiogenic shock, AMI, ADHF, and more 🚨🫀📘 👉 Read more: https://t.co/vdLetdKIpX @EACVIPresident @ACVCPresident

[Rebecca Steinberg, MD, MSc @RSteinbergMD]

Session 4 of @ChiHForum focuses on the good, the bad, and the ugly of LVAD hemodynamics, with sessions focused on pre-LVAD assessment, hemodynamics with LVAD complications, and the prediction of cardiac recovery. #ChiHemos2025 @CardioNerds

[Cory Sejo, MD @CocoSejo]

Hype for hemodynamics!
#ChiHemos2025
@catweneboah @RSteinbergMD @CardioNerds

[Rebecca Steinberg, MD, MSc @RSteinbergMD]

Session 1: Beyond Baseline Hemodynamics at @ChiHForum off to a strong start! 🦾 Check out a few highlights from the session here: #ChiHemos2025 @CardioNerds

[Cory Sejo, MD @CocoSejo]

Anthony P. Carnicelli, MD, provides a good framework for evaluation and management of PAH in the ICU!
1) Airway mgmt- just the right PEEP
2) MCS - VA ECMO >>> RV-only support.
3) Serial HDs are helpful to guide tx @RyanTedfordMD
4) New meds - role unclear - TBD
#ChiHemos2025

[Cory Sejo, MD @CocoSejo]

Engaging analysis of measuring RV reserve with @cla_baratto!
📌 Invasive PV loops are best, but challenging
📌 Echo via TAPSE/PASP --> simple, precise, but open to criticism
📌 Dynamic assessment with exercise
🗝️ For evaluation: "Something is better than nothing"
#ChiHemos2025

[Cory Sejo, MD @CocoSejo]

Additional nice takeaways for management and risk stratification! From @Jonathan_PaulMD
#ChiHemos2025

[Cory Sejo, MD @CocoSejo]

@Jonathan_PaulMD provides a fantastic talk on HD changes seen in acute PE.
🗝️ Intermediate risk patients are sicker than you may think.
🗝️ Metrics for risk: PESI, RV/LV ratio, TTE. All imperfect.
🗝️ Hemodynamics can help stratify risk!
#ChiHemos2025

[Cory Sejo, MD @CocoSejo]

🗝️ Targeting compliance may be a better metric and future goal to improve outcomes!

[Cory Sejo, MD @CocoSejo]

Dr. Marc R. Pritzker, MD walks us through changing perspectives in our treatment targets for PAH.
📌Trials focus on vasodilators with modest effect
📌PVR not well associated with outcomes--> but compliance does!
#ChiHemos2025

[Mark Belkin @MarkBelkinMD]

After months of Zoom calls and emails, great to spend time in-person with the Guest Editors of the @JCardFail Focus Issue on Hemodynamics @ChiHForum #ChiHemos2025

Check out the issue here! https://t.co/YhAspY2yjw

[Cory Sejo, MD @CocoSejo]

Current testing with vasodilators or response to LV unloading (with Impella), with subsequent improvement in PAPi, can predict good RV outcomes.
🗝️ RV failure after LVAD remains difficult to predict, and it requires ongoing investigation.
#ChiHemos2025

[Cory Sejo, MD @CocoSejo]

@JTThibs provides wonderful context for how to predict RV failure after LVAD so that we may avoid it.
📌 Various scores: (RVSWI, CVP/PCWP/PAPi)
📌 Integrating these scores is helps only modestly (max c-statistic around 0.75 with STOP-RVF) https://t.co/0Nx4FAKmg7
#ChiHemos2025

[Chelsea Amo Tweneboah, MD @catweneboah]

🎯Excercise wedge pressure-flow relationships are highly diagnostic and prognostic
���Excercise hemodynamic testing is safe, feasible and powerful
🎯improves diagnostic accuracy for HFpEF, deeper physiologic phenotyping, and identifies deficits limiting pts exercise capacity

[Chelsea Amo Tweneboah, MD @catweneboah]

#ChiHemos2025
The Advanced Analysis of PV Loops with Dr. Dan Burkoff @ChiHForum @CardioNerds
👉As PV Loops move toward routine clinical use , we must interpret correctly
👉Ees alone is not enough ; Vo matters, esp after interventions like TAVR

[Cory Sejo, MD @CocoSejo]

@BurkhoffMd provides fantastic context for understanding how to critically analyze PV loops!
⚡️ Goal/hope: PV loops will arrive in clinical practice
⚡️ Understanding derivations and assumptions will be critical for interpreting PV loops
#ChiHemos2025

[Chelsea Amo Tweneboah, MD @catweneboah]

For further reading : https://t.co/7d5PfPgm4h

Informative Tweetorial by @AHajduczok ➡️: https://t.co/FnLhiDO4vO